By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Seahorse Bioscience yesterday said that it has raised $5 million in a Series D private financing.

The North Billerica, Mass.-based maker of cell analysis instruments said that it would use proceeds form the offering to expand its domestic and international sales and marketing efforts for its XF series analyzers for measuring cell metabolism.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.